CRYP:AU:AU-BetaShares Crypto Innovators ETF (AUD)

ETF | Others |

Last Closing

USD 4.56

Change

-0.08 (-1.72)%

Market Cap

N/A

Volume

0.18M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VAS:AU Vanguard Australian Shares

+0.16 (+0.16%)

USD 16.05B
VGS:AU Vanguard MSCI International Sh..

+0.47 (+0.37%)

USD 8.59B
IVV:AU iShares Core S&P 500 AUD

+0.15 (+0.27%)

USD 8.26B
QUAL:AU VanEck Vectors MSCI World ex A..

+0.25 (+0.46%)

USD 6.31B
IOZ:AU Ishares Core S&P/Asx 200

+0.06 (+0.18%)

USD 5.96B
STW:AU SPDR® S&P/ASX 200 Fund

+0.16 (+0.21%)

USD 5.61B
HNDQ:AU BetaShares NASDAQ 100 ETF - Cu..

+0.35 (+0.88%)

USD 4.86B
NDQ:AU Betashares Nasdaq 100

+0.26 (+0.61%)

USD 4.83B
A200:AU BetaShares Australia 200

+0.09 (+0.07%)

USD 4.72B
VTS:AU Vanguard US Total Market Share..

+1.09 (+0.26%)

USD 4.70B

ETFs Containing CRYP:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.62% 7% C- 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.62% 6% D- 45% F
Trailing 12 Months  
Capital Gain 65.82% 99% N/A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 65.82% 99% N/A 91% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 35.72% 100% F 79% B-
Dividend Return 35.72% 99% N/A 79% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 52.84% 1% F 38% F
Risk Adjusted Return 67.60% 76% C+ 90% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.